Sorafenib With TACE to Treat Hepatocellular Carcinoma

NCT00478374 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Sorafenib
PROCEDURE: Transarterial chemoembolisation with doxorubicin

Sponsor

University of Bern